OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19?
Kátia Nunes da Silva, André Luiz Nunes Gobatto, Zaquer Suzana Munhoz Costa-Ferro, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 23

Showing 23 citing articles:

Mesenchymal stem cell treatment for COVID-19
Ruonan Xu, Zhiqian Feng, Fu‐Sheng Wang
EBioMedicine (2022) Vol. 77, pp. 103920-103920
Open Access | Times Cited: 56

Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives
Weiqi Yao, Lei Shi, Yun Zhang, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23

Functional heterogeneity of mesenchymal stem cells and their therapeutic potential in the K18-hACE2 mouse model of SARS-CoV-2 infection
Kátia Nunes da Silva, Fernanda Martins Marim, Gisele Vieira Rocha, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access

Functional enhancement strategies to potentiate the therapeutic properties of mesenchymal stromal cells for respiratory diseases
Miquéias Lopes‐Pacheco, Patrícia R. M. Rocco
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11

GMP-Compliant Extracellular Vesicles Derived From Umbilical Cord Mesenchymal Stromal Cells: Manufacturing and Preclinical Evaluation in ARDS treatment
Zaquer Suzana Munhoz Costa-Ferro, Gisele Vieira Rocha, Kátia Nunes da Silva, et al.
Cytotherapy (2024) Vol. 26, Iss. 9, pp. 1013-1025
Closed Access | Times Cited: 3

Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options
Débora B. Mello, Fernanda Mesquita, Danúbia Silva dos Santos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6063-6063
Open Access | Times Cited: 3

Proteomics of serum-derived extracellular vesicles are associated with the severity and different clinical profiles of patients with COVID-19: An exploratory secondary analysis
Adriana Franco Paes Leme, Sami Yokoo, Ana Gabriela Costa Normando, et al.
Cytotherapy (2024) Vol. 26, Iss. 5, pp. 444-455
Closed Access | Times Cited: 2

Application of exosomes for the alleviation of COVID‐19‐related pathologies
Aysa Rezabakhsh, Mahdi Mahdipour, Alireza Nourazarian, et al.
Cell Biochemistry and Function (2022) Vol. 40, Iss. 5, pp. 430-438
Open Access | Times Cited: 10

Stem cell therapy for COVID-19 pneumonia
Maziar Malekzadeh Kebria, Peiman Brouki Milan, Noshad Peyravian, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 8

Mesenchymal stem cells and their potential therapeutic benefits and challenges in the treatment and pathogenesis of gastric cancer
Asma'a H. Mohamed, Alaa Shafie, Waleed Al Abdulmonem, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155422-155422
Closed Access | Times Cited: 1

Innovative approaches to tissue engineering: Utilizing decellularized extracellular matrix hydrogels for mesenchymal stem cell transport
Fatemeh Soltanmohammadi, Adel Mahmoudi Gharehbaba, Effat Alizadeh, et al.
International Journal of Biological Macromolecules (2024) Vol. 290, pp. 138893-138893
Closed Access | Times Cited: 1

Mesenchymal stromal cell delivery as a potential therapeutic strategy against COVID-19: Promising evidence from in vitro results
Panagiotis Mallis, Theofanis Chatzistamatiou, Zetta Dimou, et al.
World Journal of Biological Chemistry (2022) Vol. 13, Iss. 2, pp. 47-65
Open Access | Times Cited: 7

Cell-Free Supernatant Derived from a Lactobacillus casei BL23 Culture Modifies the Antiviral and Immunomodulatory Capacity of Mesenchymal Stromal Cells
Szabolcs Muzsai, Ore-Matan Maryanovsky, Roland Ander, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1521-1521
Open Access | Times Cited: 2

Impact of Stressors on The Mental and Physical Health of Professionals Working in Intensive Care Units During The COVID-19 Pandemic
Marcos Aurélio, Costa Luna, Roberto Badaró, et al.
International Journal of Nursing and Health Care Research (2024) Vol. 7, Iss. 5
Open Access

Current status in cellular-based therapies for prevention and treatment of COVID-19
Dima Hattab, Mumen F. A. Amer, Amirah Mohd Gazzali, et al.
Critical Reviews in Clinical Laboratory Sciences (2023) Vol. 60, Iss. 5, pp. 321-345
Open Access | Times Cited: 1

Rationale for combined therapies in severe-to-critical COVID-19 patients
Aitor Gonzaga, Etelvina Andreu, Luis Blasco, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1

SEVERE CORONAVIRUS DISEASE 2019: FROM PATHOGENESIS TO THERAPY
Jean‐Marc Cavaillon, Antonio Artigas, Andreas Barratt‐Due, et al.
Shock (2022) Vol. 59, Iss. 3S, pp. 10-15
Closed Access | Times Cited: 1

Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease
Syeda A. Mina, Ibrahim N. Muhsen, Shahrukh K. Hashmi
Current Opinion in Hematology (2022) Vol. 30, Iss. 1, pp. 22-27
Closed Access | Times Cited: 1

Terapi Sel Punca dan Tata Laksana Covid-19
Dito Anurogo, Zahradiva Putu Fitria Hermawan, Nur Rahmah Awaliah, et al.
MEDICINUS (2023) Vol. 36, Iss. 1, pp. 11-19
Open Access

Novel Coronavirus disease (COVID-19): physiology to pathophysiology and therapeutics including herbal medicines
Shah Mohammad Abbas Waseem, Syed Mehdi
Infectious Diseases and Herbal Medicine (2023) Vol. 4, Iss. 1
Open Access

Page 1

Scroll to top